Australia's largest stock trading and investment forum Australia's #1 stock forum

GXY

Click for more information

0.00%

$5.28 galaxy resources limited

Ann: 2017 Half Year Financial Report, page-202

First 202 Last

Share
Profile

Follow
Upstart777

3,795 Posts.

227

01/09/17

10:18

Post #: 26922909
Share

Originally posted by Bron ↑

Hi Upstart I've heard that accountants think that they have super powers, that everyone in the accounting department counts, and that it is their job to clear their calculators at least 5 times at the close of each business day. It's not a boring career for those that like the numbers, and behind every profitable business, there is a calculating and tabulating accountant, overseeing every financial transaction going down. And Galaxy would have the best of them, as they go about the complicated processes of financing and developing their remaining assets, growing their market cap and share price to reflect the true value, as we all know that Galaxy should be trading at prices much higher than where it has been trading in recent weeks, and for the first half of this year.
Prices of $4.07 and $3.52 will be nice share price targets to reach, and no doubt going even higher in future years, as Galaxy makes steady progress from its asset developments and future income. This year has at least provided many opportunities for a good set-up position in Galaxy.

Expand

Good Morning @Bron
It certainly makes a nice change for holders to be counting their profits (or return to black) instead of reading how their days are numbered.....GLTAH

GXY Price at posting: $1.96 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 1 more message in this thread...

First 202 Last

Add GXY (ASX) to my watchlist